Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
| Autor: | Craig, Timothy *, Magerl, Markus, Levy, Donald S, Reshef, Avner, Lumry, William R, Martinez-Saguer, Inmaculada, Jacobs, Joshua S, Yang, William H, Ritchie, Bruce, Aygören-Pürsün, Emel, Keith, Paul K, Busse, Paula, Feuersenger, Henrike, Pawaskar, Dipti, Jacobs, Iris, Pragst, Ingo, Doyle, Mittie K |
|---|---|
| Zdroj: | In The Lancet 5-11 March 2022 399(10328):945-955 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|